Dr. Cornelis Bart, Medische Expertise
0538.853.509 · rovalta.com · 26/09/2026
NORMAL SITUATION
Dr. Cornelis Bart, Medische Expertise
Company — Normal situation.
Financial year 2025 · Closed on 29/08/2025
Net result-1,8 k €-160,1 %over 1 year
Gross margin-10,5 k €+14,8 %over 1 year
Equity18,6 k €-96,7 %over 1 year
Overview
Identity
Source · BCE/KBODr. Cornelis Bart, Medische Expertise is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0538.853.509
- Legal form
- Private company with limited liability
- Contributed capital
- 18 600,00 €
- Latest accounts
- 29/08/2025
Joint committees (1)
- 33004
Signals
Healthy social debts
Financials
Source · NBB, 12 filingsTrend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -10,5 k € | +14.8% | -12,4 k € | -103% | 428,5 k € | -0.6% | 431,3 k € | -13.9% | 501,2 k € |
| EBITDA | -9,8 k € | +33.4% | -14,7 k € | -107% | 198,9 k € | -46.4% | 371 k € | -16.0% | 441,8 k € |
| Operating result | -2,4 k € | +92.5% | -31,4 k € | -118% | 171,2 k € | -43.9% | 305 k € | -15.7% | 361,7 k € |
| Net result | -1,8 k € | -160% | -708,5 € | -101% | 118,9 k € | -6.5% | 127,1 k € | -52.1% | 265,3 k € |
| Balance sheet | |||||||||
| Equity | 18,6 k € | -96.7% | 559,9 k € | -0.1% | 560,6 k € | +26.9% | 441,7 k € | -48.6% | 860 k € |
| Total assets | 558,1 k € | -26.6% | 760 k € | -17.9% | 926,2 k € | +1.3% | 914,5 k € | -16.8% | 1,1 M € |
| Cash | 546,5 k € | +3670% | 14,5 k € | -93.9% | 236 k € | -44.5% | 425,5 k € | -10.2% | 473,9 k € |
| Debts | 539,5 k € | +183% | 190,3 k € | -45.7% | 350,3 k € | -24.2% | 462,4 k € | +103% | 227,7 k € |
| Other | |||||||||
| Workforce | – | – | 1,0 ETP | 0.0% | 1,0 ETP | 0.0% | 1,0 ETP | ||
Board of directors
Source · NBB, accounts to 29/08/20251 active · 7 ended
Active mandates
Jin Yan
ActiveEnded mandates
Jin Yan
EndedJin Yan
EndedBart Cornelis
EndedBart Cornelis
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 29/08/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 8 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 11/12/2025 | 23/06/2025 | 02/10/2024 | 21/12/2023 | 29/09/2022 | 19/07/2021 |
| General meeting | 29/08/2025 | 11/06/2025 | 12/09/2024 | 18/12/2023 | 13/09/2022 | 09/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 29/08/2025 | 29/08/2025 | 11/12/2025 | Dutch | |
| Micro model | 31/12/2024 | 11/06/2025 | 23/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 12/09/2024 | 02/10/2024 | Dutch | |
| Abridged model | 31/12/2022 | 18/12/2023 | 21/12/2023 | Dutch | |
| Abridged model | 31/12/2021 | 13/09/2022 | 29/09/2022 | Dutch | |
| Abridged model | 31/12/2020 | 09/06/2021 | 19/07/2021 | Dutch | |
| Micro model | 31/12/2019 | 26/08/2020 | 17/09/2020 | Dutch | |
| Micro model | 31/12/2018 | 12/06/2019 | 26/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 13/06/2018 | 29/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 14/06/2017 | 29/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 08/06/2016 | 16/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 10/06/2015 | 18/06/2015 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 29/08/20251 active · 7 ended
Active mandates
Jin Yan
ActiveEnded mandates
Jin Yan
EndedJin Yan
EndedBart Cornelis
EndedBart Cornelis
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution03/10/2025RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - ONTSLAGEN - BENOEMINGEN
- Mandates06/02/2025ONTSLAGEN - BENOEMINGEN
- Other02/10/2014DIVERSEN
- Other25/09/2013RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-1,8 k €↓
- 2024Annual accounts 2024-708,5 €↓
- 2023Annual accounts 2023118,9 k €↓
- 2022Annual accounts 2022127,1 k €↓
- 2021Annual accounts 2021265,3 k €↑
- 2019Annual accounts 2019198,7 k €↑
- 2018Annual accounts 2018155,9 k €↑
- 2017Annual accounts 201791 k €↓
- 2016Annual accounts 2016114,2 k €↑
- 2015Annual accounts 201594,9 k €↓
- 2014Annual accounts 2014187,1 k €